Search results
Amgen Stock Jumps on Obesity Drug Optimism. What Comes Next.
Barrons.com· 2 hours agoFEATURE Shares of Amgen spiked higher Friday after the company said it saw encouraging signs from...
Weight loss drug shortage: Zepbound and Wegovy in short supply, says FDA
BenefitsPRO· 23 hours agoThe U.S. Food and Drug Administration updated its drug shortage database in April to reflect that...
Hands on Wisconsin: Far out, man! Marijuana gets rescheduled
Wisconsin State Journal· 2 hours agoThe U.S. attorney general is suggesting that marijuana be reclassified as a less dangerous drug.
Amgen Soars as CEO Touts Experimental Obesity Drug’s Progress
Bloomberg via Yahoo Finance· 2 hours ago(Bloomberg) -- Amgen Inc.’s shares soared after its chief executive officer said he was “very...
Undercover drug operation “Street Sweeper” leads to arrest of more than 100 people in Southern...
San Jose Mercury News· 2 hours agoOfficials said that community members and businesses recently had complained to police about...
Ryan Garcia fails drug test. His opponent, Devin Haney, is connected to Victor Conte.
USA TODAY Sports via Yahoo Sports· 21 hours agoThe news on Wednesday that boxer Ryan Garcia failed drug tests before his three-knockdown upset of...
Novo Slides as Amgen Fuels Obesity Drug Competition Fears
Bloomberg via Yahoo Finance· 1 hour ago(Bloomberg) -- Novo Nordisk A/S shares fell as a US rival’s comments on an experimental obesity drug...
Boy, 15 months, died after ingesting drugs. Parents charged with aggravated manslaughter
Ocala Star Banner via Yahoo News· 20 hours agoA man and woman have been arrested on charges of aggravated manslaughter of a child in connection...
Earnings call: Kymera Therapeutics reports progress in drug development By Investing.com
Investing.com· 2 hours agoKymera Therapeutics, during their first quarter 2024 earnings call, provided a comprehensive update...
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data
Reuters via AOL· 3 hours agoNovo Nordisk were last down 4.4% by 1022 GMT, having hit their lowest in two months earlier in the...